Precision Oncology: Changing the Game for Metastatic Cancer

Precision Oncology: Changing the Game for Metastatic Cancer

A more targeted way to treat cancer- right at the source.

When cancer spreads to the liver, it often becomes one of the most difficult and life-threatening stages of the disease. Liver metastases are a leading cause of death in advanced cancer, yet treatment options remain limited, especially for patients whose tumors cannot be surgically removed. 

In this segment, we visit a participating treatment center to understand why the liver presents such a unique challenge and how traditional treatments like systemic chemotherapy and localized therapies often fall short. We then explore HEPZATO KIT, a liver-directed therapy that delivers high-dose chemotherapy directly to the liver while filtering the blood before it returns to the body. 

Currently approved for patients with metastatic uveal melanoma affecting the liver, and being studied in more common cancers, this approach represents a promising shift toward more targeted, organ-specific cancer care.

Facebook
Twitter
LinkedIn
Pinterest